BioNTech kündigt strategische Partnerschaft mit der Regierung des Vereinigten Königreichs an, um bis 2030 bis zu 10.000 Patientinnen und Patienten mit personalisierten mRNA-Krebsimmuntherapien zu behandeln
January 05, 2023 19:01 ET
|
BioNTech SE
Die mehrjährige Vereinbarung fokussiert sich auf drei strategische Bereiche: Krebsimmuntherapien, Impfstoffe gegen Infektionskrankheiten und weitere Expansion von BioNTech im Vereinigten...
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030
January 05, 2023 19:01 ET
|
BioNTech SE
Multi-year collaboration focuses on three strategic pillars: cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech’s footprint in the UKBioNTech aims to design and roll out...
RxCelerate Acquires Methuselah Health and Launches ProQuant™ World-Beating Proteomics Service
November 22, 2022 08:00 ET
|
RxCelerate
CAMBRIDGE, England, Nov. 22, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery...
TILT Holdings’ Commonwealth Alternative Care Hosts Grand Opening at Newest Dispensary in Cambridge
September 16, 2022 07:30 ET
|
TILT Holdings Inc.
PHOENIX, Sept. 16, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation...
TILT Holdings Receives Approval to Launch Medical Use Cannabis Operations at its Cambridge, Massachusetts Dispensary
August 30, 2022 08:00 ET
|
TILT Holdings Inc.
PHOENIX, Aug. 30, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation...
Copia Scientific Announces the Acquisition of Atlantic Lab Equipment
August 04, 2022 08:00 ET
|
Copia Scientific
TAUNTON, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Copia Scientific, LLC, has acquired Atlantic Lab Equipment (originally formed in 2002). With the addition of Atlantic Lab Equipment, Copia has...
RxCelerate Launch RxNfinity™: A Next-Generation Machine Learning-Enabled Small Molecule Discovery Platform
July 19, 2022 08:00 ET
|
RxCelerate
CAMBRIDGE, England, July 19, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international outsourced drug discovery and development platform, today revealed details of a new small molecule discovery...
Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 16, 2020 17:05 ET
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference
September 11, 2020 15:00 ET
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020
August 11, 2020 06:30 ET
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...